Comparative Acceptability of Tobacco and Menthol Flavored E-cigarettes
NCT ID: NCT04996940
Last Updated: 2023-09-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2021-06-20
2021-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
NCT05555069
Use Behavior, Nicotine Uptake, and Subjective Effects Comparison of Tobacco and Menthol e-Liquids by ENDS Consumers
NCT05134415
Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes
NCT03164668
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2
NCT03168191
Evaluation of Cessation Preferences of Menthol Smoker
NCT02020005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tobacco then Menthol
A 30-minute session with tobacco flavor then a 30-min session with menthol flavor
E-cigarette product
Participants will be randomized 1:1 to e-cigarette flavor order either:
1. tobacco e-cigarette
2. menthol e-cigarette
Menthol then tobacco
A 30-minute session with menthol flavor then a 30-min session with tobacco flavor
E-cigarette product
Participants will be randomized 1:1 to e-cigarette flavor order either:
1. tobacco e-cigarette
2. menthol e-cigarette
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
E-cigarette product
Participants will be randomized 1:1 to e-cigarette flavor order either:
1. tobacco e-cigarette
2. menthol e-cigarette
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-Hispanic African American or white/Caucasian,
* ≥21 years old, smoke 5-30 cigarettes per day,
* daily cigarette smoker
* smoked at current rate for at least 6 months
* interested in trying e-cigarettes
* not interested in or unable/unwilling to quit cigarette smoking
* willing to complete one in-person study visits
Exclusion Criteria
* use of smoking cessation pharmacotherapy in the past 30 days
* use of non-cigarette tobacco products in the past 30 days
* use of e-cigarettes \>5x in lifetime
* use of e-cigarettes ≥4 of the past 30 days
* weight \< 110 lbs
* uncontrolled hypertension (systolic BP ≥ 180 or diastolic BP ≥ 105)
* pregnant, plans to become pregnant, or breastfeeding
* live \>10 miles from study site (Fairway CRU)
* current enrollment is a research study or program that aims to alter tobacco use
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Medical Center
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
145421a
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.